HANNAH JENKINS: Open Payments
NPI 1760888671 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$968 in 64 payments from 19 companies in 2025. Trend: 2023 $1,133 · 2024 $1,055 · 2025 $968
Food & beverage: $968
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $188 |
| ABBVIE INC. | 11 | $151 |
| Novo Nordisk Inc | 15 | $145 |
| PFIZER INC. | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $75 |
| Axsome Therapeutics, Inc. | 3 | $46 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| Dexcom, Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $22 |
Products named: MOUNJARO, JARDIANCE, Wegovy, CAPLYTA, QULIPTA, Auvelity, VOQUEZNA, VRAYLAR.
Industry payments across KS — which companies pay providers there.
